Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

news.google.com

"TAK-573 multiple myeloma" - Google News

Get the latest updates from "TAK-573 multiple myeloma" - Google News directly as they happen.

Follow now < 10 followers

Latest posts

Last updated about 2 years ago

Looking Forward into 2022 in Multiple Myeloma With Robert Orlowski, MD, PHD, MD Anderson Cancer Center - Myeloma Crowd News

about 2 years ago

Looking Forward into 2022 in Multiple Myeloma With Robert Orlowski, MD, PHD...

Modakafusp Alfa Elicits Single-Agent Activity, Represents a Novel Option in Relapsed/Refractory Myeloma - OncLive

about 2 years ago

Modakafusp Alfa Elicits Single-Agent Activity, Represents a Novel Option in Relapsed/Refractory Myeloma...

Dr. Vogl on the Utilization of Modakafusp in Relapsed/Refractory Multiple Myeloma - OncLive

over 2 years ago

Dr. Vogl on the Utilization of Modakafusp in Relapsed/Refractory Multiple Myeloma  OncLive

Fierce Pharma Asia—Merck, Eisai's failed Lenvima trial; J&J, Legend's CAR-T data; AstraZeneca-Samsung COVID pact - FiercePharma

over 2 years ago

Fierce Pharma Asia—Merck, Eisai's failed Lenvima trial; J&amp;J, Legend's CAR-T data; AstraZeneca-Samsung...

Applied BioMath, LLC Announces Participation at the American Conference on Pharmacometrics (ACoP12) - WFMZ Allentown

over 2 years ago

Applied BioMath, LLC Announces Participation at the American Conference on Pharmacometrics (ACoP12)...

Applied BioMath, LLC Announces Participation at the American Conference on Pharmacometrics (ACoP12) - PRNewswire

over 2 years ago

Applied BioMath, LLC Announces Participation at the American Conference on Pharmacometrics (ACoP12)...

Takeda Pharmaceutical Company Limited (TAK) CEO Christophe Weber on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha

over 2 years ago

Takeda Pharmaceutical Company Limited (TAK) CEO Christophe Weber on Q2 2022 Results...

Go or go go? J&J’s cell therapy heads to the FDA - Vantage

over 2 years ago

Go or go go? J&amp;J’s cell therapy heads to the FDA  Vantage

Multiple Myeloma Pipeline Analysis Demonstrates Stunning Growth With A Gamut of Pharma Companies Involved Worldwide - Yahoo Finance

almost 3 years ago

Multiple Myeloma Pipeline Analysis Demonstrates Stunning Growth With A Gamut of Pharma...